🔎 Trials Near Me

Home › Cancro ai polmoni › Maine

Studi clinici su Cancro ai polmoni nello stato di Maine

12 studi su Cancro ai polmoni cercano partecipanti presso sedi nello stato di Maine.

Città nello stato di Maine

Testo ufficiale dello studio (inglese)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Harold Alfond Center for Cancer Care, Augusta
  • MaineHealth Waldo Hospital, Belfast
  • Lafayette Family Cancer Center-EMMC, Brewer
  • e altri 5
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Harold Alfond Center for Cancer Care, Augusta
  • MaineHealth Waldo Hospital, Belfast
  • Lafayette Family Cancer Center-EMMC, Brewer
  • e altri 9
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

  • Lafayette Family Cancer Center-EMMC, Brewer
In reclutamentoFase 3
Età 70 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06096844

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Harold Alfond Center for Cancer Care, Augusta
  • MaineHealth Maine Medical Center- Scarborough, Scarborough
  • MaineHealth Cancer Care and IV Therapy - South Portland, South Portland
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06498635

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  • Maine Medical Center, Portland
  • MaineHealth Cancer Care and Blood Disorders Scarborough, Scarborough
  • MaineHealth Cancer Care and IV Therapy - South Portland, South Portland
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06758401

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

  • MaineHealth Maine Medical Center - Portland, Portland
  • MaineHealth Cancer Care Center of York County, Sanford
  • MaineHealth Maine Medical Center- Scarborough, Scarborough
  • e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 ago 2026 · NCT05624996

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Lafayette Family Cancer Center-EMMC, Brewer
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 giu 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • Lafayette Family Cancer Center-EMMC, Brewer
In reclutamentoFase 2
18 Minutes · Tutti i sessi · Aggiornato il 5 mag 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • Harold Alfond Center for Cancer Care, Augusta
  • MaineHealth Waldo Hospital, Belfast
  • Lafayette Family Cancer Center-EMMC, Brewer
  • e altri 5
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 mag 2026 · NCT06616584

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Scarborough
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 28 ott 2025 · NCT03452774

Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.